North America Cell-based Assays Market - Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CELL BASED ASSAYS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 NORTH AMERICA CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)

2.8 DBMR MARKET POSITION GRID

2.9 DBMR VENDOR SHARE ANALYSIS

2.10 MULTIVARIATE MODELING

2.11 PRODUCTS LIFELINE CURVE

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES

3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES

3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE

3.2 RESTRAINT

3.2.1 STRINGENT REGULATORY REQUIREMENTS

3.2.2 HIGH COST OF INSTRUMENTATION

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS

3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS

3.4 CHALLENGES

3.4.1 CHALLENGING ANALYSIS PROCEDURE

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TYPE

6.1 OVERVIEW

6.2 CELL VIABILITY ASSAY

6.3 CYTOTOXICITY ASSAY

6.4 CELL PROLIFERATION ASSAY

6.5 CELL DEATH ASSAY

6.6 OTHERS

7 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 ASSAY KITS

7.2.2 CELL LINES

7.2.2.1 PRIMARY CELL LINES

7.2.2.2 STEM CELL LINES

7.2.2.3 IMMORTALIZED CELL LINES

7.2.3 REAGENTS

7.2.4 MICROPLATES

7.3 SERVICES

7.4 INSTRUMENTS AND SOFTWARE

8 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 HIGH THROUGHPUT SCREENING

8.3 FLOW CYTOMETRY

8.4 HIGH CONTENT SCREENING

8.5 LABEL FREE DETECTION

9 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DISCOVERY

9.2.1 PREDICTIVE TOXICOLOGY

9.2.2 PHARMACODYNAMIC STUDIES

9.2.3 ADME RESEARCH

9.3 BASIC RESEARCH

9.4 OTHERS

10 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY END USER

10.1 OVERVIEW

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.3 CONTRACT RESEARCH ORGANIZATIONS

10.4 ACADEMIC & RESEARCH INSTITUTIONS

10.5 GOVERNMENT ORGANIZATIONS

10.6 OTHERS

11 NORTH AMERICA CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT

11.3 INDIRECT

12 NORTH AMERICA CELL BASED ASSAY MARKET, BY GEOGRAPHY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 NORTH AMERICA CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 COMPANY PROFILE

15.1 GENERAL ELECTRIC

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 DANAHER

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 AGILENT TECHNOLOGIES, INC.

15.3.1.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 THERMO FISHER SCIENTIFIC INC

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 MERCK KGAA

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 PERKINELMER INC, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BIO-RAD LABORATORIES, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 ATCC

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 AURELIA BIOSCIENCE LTD.

15.9.1 COMPANY SNAPSHOT

15.9.2 SERVICE PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.10 BD

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENTS

15.11 BIOAGILYTIX LABS

15.11.1 COMPANY SNAPSHOT

15.11.2 SERVICE PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BIOVISION INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CELL SIGNALING TECHNOLOGY, INC.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 CISBIO

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 ENZO BIOCHEM INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENT

15.16 EUROFINS SCIENTIFIC

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT AND SERVICE PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 LAKEPHARMA, INC.

15.17.1 COMPANY SNAPSHOT

15.17.2 SERVICE PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 LONZA

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 SERVICE PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 MILTENYI BIOTEC

15.19.1 COMPANY SNAPSHOT

15.19.2.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.20 XENO DIAGNOSTICS, LLC.

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

UU

TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)

TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)

TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 4 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 NORTH AMERICA CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 NORTH AMERICA CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 U.S. CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 46 U.S. CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 47 U.S. CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 48 U.S. CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 49 U.S. CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 50 U.S. CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 51 U.S. DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 52 U.S. CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 53 U.S CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 54 CANADA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 55 CANADA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 56 CANADA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 57 CANADA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 58 CANADA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 59 CANADA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 CANADA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 CANADA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 CANADA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 63 MEXICO CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 64 MEXICO CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 MEXICO CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 66 MEXICO CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 67 MEXICO CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 68 MEXICO CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 MEXICO DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 71 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)